Cat.#: ACPP-1245
| Despition | CRMP2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg | inquiry |
| ACPP-1505 | Human CRYGD Protein (AC1505) | 5 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1802 | Human STAC Protein (AC1802) | 5 µg | inquiry |
| ACPP-1423 | Human ALDH5A1 Protein (AC1423) | 2 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1252 | Robo3 Blocking Peptide (AC1252) | 250 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1790 | Rat MANF Protein (AC1790) | 5 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.